Purchases and Sales Made in Q3 2022 in Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY) during Q3 2022. The information is specifically focused on institutions that hold shares of Inozyme Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
168K+ 6.35% |
$431K - $913K
|
2.81M
$8.48M
|
|
|
Nov 14, 2022
Q3 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
50K+ 1.96% |
$128K - $273K
|
2.6M
$7.84M
|
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
46K+ 52.63% |
$118K - $251K
|
133K
$403K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
37.1K+ 31.36% |
$95.3K - $202K
|
155K
$469K
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
27.3K+ 55.65% |
$70.2K - $149K
|
76.4K
$231K
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
16.8K+ 7.73% |
$43.1K - $91.3K
|
234K
$706K
|
|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
16.1K+ 15.86% |
$41.3K - $87.7K
|
118K
$355K
|
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
14K+ 106.64% |
$35.9K - $76.1K
|
27K
$81.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
13.2KNew |
$33.9K - $71.8K
|
13.2K
$39.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
9.46K+ 0.81% |
$24.3K - $51.5K
|
1.18M
$3.55M
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
2.92K+ 41714.29% |
$7.5K - $15.9K
|
2.93K
$8.84K
|
|
|
Nov 14, 2022
Q3 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
1.53KNew |
$3.94K - $8.35K
|
1.53K
$4.63K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
221+ 47.12% |
$568 - $1.2K
|
690
$2.08K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-20- 11.3% |
$51.4 - $109
|
157
$474
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-1.66K- 7.56% |
$4.25K - $9.02K
|
20.2K
$61.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-2.09K- 0.49% |
$5.37K - $11.4K
|
428K
$1.29M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-2.91K- 1.68% |
$7.47K - $15.8K
|
170K
$514K
|
|
|
Nov 14, 2022
Q3 2022
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-3.84K- 0.58% |
$9.86K - $20.9K
|
661K
$2M
|
|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-5.85K- 3.41% |
$15K - $31.9K
|
165K
$500K
|
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-6.69K- 14.23% |
$17.2K - $36.4K
|
40.3K
$122K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-10.2K- 8.42% |
$26.2K - $55.5K
|
111K
$334K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-11.2K- 0.82% |
$28.7K - $60.8K
|
1.34M
$4.06M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-18.9K- 45.88% |
$48.5K - $103K
|
22.3K
$67.3K
|
|
|
Nov 14, 2022
Q3 2022
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-20.1K- 29.17% |
$51.7K - $110K
|
48.8K
$147K
|
|
|
Nov 09, 2022
Q3 2022
|
Chi Advisors LLC
New York, NY |
SELL
|
- |
-37.5K- 1.85% |
$96.4K - $205K
|
2M
$6.03M
|
|
|
Nov 14, 2022
Q3 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-224K- 24.13% |
$577K - $1.22M
|
706K
$2.13M
|
|
|
Nov 14, 2022
Q3 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-606K- 22.47% |
$1.56M - $3.3M
|
2.09M
$6.31M
|